Miller T L, Awnetwant E L, Evans S, Morris V M, Vazquez I M, McIntosh K
Combined Program in Pediatric Gastroenterology and Nutrition, Children's Hospital, Boston, MA 02115, USA.
Pediatrics. 1995 Oct;96(4 Pt 1):696-702.
Malnutrition is common in pediatric human immunodeficiency virus (HIV) infection, and little is known of effective nutritional interventions. We sought to determine whether enteral supplementation with gastrostomy tube feedings would provide improvements in weight, height, body composition, immune parameters, morbidity, and mortality.
We collected clinical data on 23 HIV-infected children who were fed chronically by gastrostomy tube. The main outcome measures included weight, height, triceps skinfold thickness (TSF), arm-muscle circumference (AMC), hospital days, caloric intake, and CD4-positive T-lymphocyte count. Each of these parameters was measured or evaluated at four points: 6 months before nasogastric tube feeding, at the time nasogastric tube feeding was initiated, at the time gastrostomy tube feeding was initiated, and 6 months after gastrostomy tube feedings began.
Weight z score [-2.1 (0.14) to -1.58 (0.14)] and weight-for-height z score [-0.98 (0.16) to -0.15 (0.17)] improved with gastrostomy tube feedings. There was a trend toward improvement in weight z score with nasogastric tube feedings. Caloric intakes increased progressively with nasogastric and gastrostomy tube feedings. No improvement in height, TSF, AMC, hospital days, or CD4 counts was seen in the follow-up period. However, children who had the greatest increase in weight had the most improvement in fat stores (TSF) (r = .65, P = .002) and a decrease in hospital days after the gastrostomy tube was placed (r = -.48, P = .025). Higher age-adjusted CD4 counts and lower weight-for-height z scores at the time of enteral supplementation were significant predictors of a positive response to gastrostomy tube feedings (r = .85, P = .0001). Children who responded favorably had a 2.8-fold reduction in the risk of dying for every positive unit change in weight z score (P = .005).
Gastrostomy tube supplementation for HIV-infected children can improve weight and fat mass when other oral methods fail. Weight gain is coincident with greater caloric intakes. HIV-infected children with higher CD4 counts and lower weight-for-height z scores are likely to respond favorably to gastrostomy tube feedings. Early nutritional intervention is indicated for HIV-infected children.
营养不良在儿科人类免疫缺陷病毒(HIV)感染中很常见,而有效的营养干预措施鲜为人知。我们试图确定经胃造口管喂养进行肠内补充是否能改善体重、身高、身体成分、免疫参数、发病率和死亡率。
我们收集了23例通过胃造口管长期喂养的HIV感染儿童的临床数据。主要观察指标包括体重、身高、肱三头肌皮褶厚度(TSF)、上臂肌肉周长(AMC)、住院天数、热量摄入和CD4阳性T淋巴细胞计数。这些参数在四个时间点进行测量或评估:鼻胃管喂养前6个月、鼻胃管喂养开始时、胃造口管喂养开始时以及胃造口管喂养开始后6个月。
胃造口管喂养后,体重Z评分[-2.1(0.14)至-1.58(0.14)]和身高别体重Z评分[-0.98(0.16)至-0.15(0.17)]有所改善。鼻胃管喂养时体重Z评分有改善趋势。鼻胃管和胃造口管喂养时热量摄入逐渐增加。随访期间身高、TSF、AMC、住院天数或CD4计数均无改善。然而,体重增加最多的儿童脂肪储备(TSF)改善最大(r = 0.65,P = 0.002),胃造口管放置后住院天数减少(r = -0.48,P = 0.025)。肠内补充时年龄校正后的CD4计数较高和身高别体重Z评分较低是胃造口管喂养阳性反应的显著预测因素(r = 0.85,P = 0.0001)。反应良好的儿童体重Z评分每增加一个阳性单位,死亡风险降低2.8倍(P = 0.005)。
当其他口服方法无效时,为HIV感染儿童补充胃造口管喂养可改善体重和脂肪量。体重增加与热量摄入增加一致。CD4计数较高且身高别体重Z评分较低的HIV感染儿童可能对胃造口管喂养反应良好。建议对HIV感染儿童进行早期营养干预。